60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Jul 24, 2026, 4:00 PM EDT
1.510
+0.030 (2.03%)
After-hours: Jul 24, 2026, 7:34 PM EDT

SXTP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.311.410.680.250.516.35
Revenue Growth
63.89%106.81%168.70%-50.40%-91.95%-
Gross Profit
0.520.630.3-0.220.085.5
Operating Income
-7.94-7.76-9.72-5.15-1.75-1.12
Net Income
-8.06-7.86-8.43-3.92-6.18-4.27
Earnings Per Share
-8.97-11.73-74.17-236.72-52.20-242.40
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
01.241.732.140.260.12
Total Debt
00.150.160.1722.6118.8
Net Cash (Debt)
-01.091.571.97-22.35-18.69
Net Cash Growth
--30.82%-20.17%---
Net Cash Per Share
-1.6213.84118.82-799.13-668.28

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.99-6.85-5.65-4.54-1.01-0.65
Capital Expenditures
-0.17-0.14-0.1-0.06--0
Free Cash Flow
-8.16-6.99-5.75-4.6-1.01-0.65
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.60%44.52%43.53%-87.15%15.42%86.61%
Operating Margin
-604.05%-550.61%-1425.88%-2032.78%-342.41%-17.69%
Pretax Margin
-576.56%-522.91%-1167.64%-1503.93%-1208.37%-67.05%
Profit Margin
-576.56%-522.91%-1167.64%-1504.02%-1208.46%-67.06%
FCF Margin
-620.61%-495.99%-844.19%-1814.28%-197.57%-10.27%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.991.685.3723.37--